Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 10,000 shares at $52.16 ($522K) on 2020-12-15, disclosed to the SEC on 2020-12-16.
Open-market sale of $522k APLS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.16 | 5,000 | $261K | 50.0% |
| 2 | $52.16 | 5,000 | $261K | 50.0% |
| Total | $52.16 avg | 10,000 | $522K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |